(Circulation. 2000;101:2902.)
© 2000 American Heart Association, Inc.
Clinical Investigation and Reports |
Cardioprotective Effects of the Na+/H+ Exchange Inhibitor Cariporide in Patients With Acute Anterior Myocardial Infarction Undergoing Direct PTCA
From the 2nd Department of Internal Medicine, Johannes Gutenberg-University, Mainz (H.-J.R., M.B.); Department of Medicine I, RWTH Aachen (J.v.D.); Department of Cardiology, University Clinic Eppendorf, Hamburg (W.T.); Department of Medicine I, University Clinic, München (K.M.S.); Department of Cardiology, University Clinic, Lübeck (G.R.); Department of Cardiology, University Clinic, Berlin (H.-P.S.); and Department of Cardiology, University Clinic, Hannover (H.D.), Germany; and the Department of Medicine, Division of Cardiology, University of Washington, Seattle (F.H.S.).
Correspondence to Hans-Jürgen Rupprecht, MD, II Department of Internal Medicine, Johannes Gutenberg University, Langenbeckstraße 1, 55101 Mainz, Germany ( e-mail rupprecht{at}2-med.klinik.uni-mainz.de) or Helmut Drexler, MD, Department of Cardiology, Medizinische Hochschule Hannover, Carl-Neubergstraße 1, 30625 Hannover, Germany (
Background—Activation of Na+/H+ exchange in myocardial ischemia and/or reperfusion leads to calcium overload and myocardial injury. Experimental studies have shown that Na+/H+ exchange inhibitors can attenuate Ca2+ influx into cardiomyocytes. We therefore performed a multicenter, randomized, placebo-controlled clinical trial to test the hypothesis that inhibition of Na+/H+ exchange limits infarct size and improves myocardial function in patients with acute anterior myocardial infarction (MI) treated with direct PTCA.
Methods and Results—One hundred patients were randomized to receive placebo (n=51) or a 40-mg intravenous bolus of the Na+/H+ exchange inhibitor cariporide (HOE 642) (n=49) before reperfusion. Global and regional left ventricular functions were analyzed by use of paired contrast left ventriculograms performed before and 21 days after PTCA and myocardial enzymes (ie, creatine kinase [CK], CK-MB, and LDH) as markers for myocardial tissue injury were evaluated. At follow-up, the ejection fraction was higher (50% versus 40%; P<0.05) and the end-systolic volume was lower (69.0 versus 97.0 mL; P<0.05) in the cariporide group. Significant improvements in some indices of regional wall motion abnormalities were observed, such as the percentage of chords with hypokinesis < -2 SD (P=0.045) and the severity of hypokinesis in the border zone of the infarct region (P=0.052). In addition, CK, CK-MB, or LDH release was significantly reduced in the cariporide patients.
Conclusions—Our findings suggest that inhibition of Na+/H+ exchange by cariporide may attenuate reperfusion injury and thereby improve the recovery from left ventricular dysfunction after MI.
Key Words: reperfusion • sodium • cariporide • myocardial infarction • angioplasty • ventricles
This article has been cited by other articles:
 |
|
 |
|
  G. W. Stone Angioplasty Strategies in ST-Segment-Elevation Myocardial Infarction: Part II: Intervention After Fibrinolytic Therapy, Integrated Treatment Recommendations, and Future Directions Circulation, July 29, 2008; 118(5): 552 - 566. [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Dirksen, G. J. Laarman, M. L. Simoons, and D. J.G.M. Duncker Reperfusion injury in humans: A review of clinical trials on reperfusion injury inhibitory strategies Cardiovasc Res, June 1, 2007; 74(3): 343 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Imahashi, F. Mraiche, C. Steenbergen, E. Murphy, and L. Fliegel Overexpression of the Na+/H+ exchanger and ischemia-reperfusion injury in the myocardium Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2237 - H2247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. G. Perez, M. R. Piaggio, I. L. Ennis, C. D. Garciarena, C. Morales, E. M. Escudero, O. H. Cingolani, G. Chiappe de Cingolani, X.-P. Yang, and H. E. Cingolani Phosphodiesterase 5A Inhibition Induces Na+/H+ Exchanger Blockade and Protection Against Myocardial Infarction Hypertension, May 1, 2007; 49(5): 1095 - 1103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. E. Cingolani and I. L. Ennis Sodium-Hydrogen Exchanger, Cardiac Overload, and Myocardial Hypertrophy Circulation, March 6, 2007; 115(9): 1090 - 1100. [Full Text] [PDF]
|
|
|
|
 |
|
 F. W. Bar, D. Tzivoni, M. T. Dirksen, A. Fernandez-Ortiz, G. R. Heyndrickx, J. Brachmann, J. H.C. Reiber, N. Avasthy, J. Tatsuno, M. Davies, et al. Results of the first clinical study of adjunctive CAldaret (MCC-135) in patients undergoing primary percutaneous coronary intervention for ST-Elevation Myocardial Infarction: the randomized multicentre CASTEMI study Eur. Heart J., November 1, 2006; 27(21): 2516 - 2523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Maekawa, J.-i. Abe, T. Shishido, S. Itoh, B. Ding, V. K. Sharma, S.-S. Sheu, B. C. Blaxall, and B. C. Berk Inhibiting p90 Ribosomal S6 Kinase Prevents Na+-H+ Exchanger-Mediated Cardiac Ischemia-Reperfusion Injury Circulation, May 30, 2006; 113(21): 2516 - 2523. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Ross, R. J. Gibbons, G. W. Stone, R. A. Kloner, R. W. Alexander, and for the AMISTAD-II Investigators A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Adenosine as an Adjunct to Reperfusion in the Treatment of Acute Myocardial Infarction (AMISTAD-II) J. Am. Coll. Cardiol., June 7, 2005; 45(11): 1775 - 1780. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Juhaszova, C. Rabuel, D. B. Zorov, E. G. Lakatta, and S. J. Sollott Protection in the aged heart: preventing the heart-break of old age? Cardiovasc Res, May 1, 2005; 66(2): 233 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Kloner and S. H. Rezkalla Cardiac protection during acute myocardial infarction: Where do we stand in 2004? J. Am. Coll. Cardiol., July 21, 2004; 44(2): 276 - 286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ten Hove and C. J.A Van Echteld Limited effects of post-ischemic NHE blockade on [Na+]i and pHi in rat hearts explain its lack of cardioprotection Cardiovasc Res, February 15, 2004; 61(3): 522 - 529. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Klass, U. M. Fischer, E. Perez, J. Easo, M. Bosse, J. H. Fischer, P. Tossios, and U. Mehlhorn Effect of the Na+/H+ exchange inhibitor eniporide on cardiac performance and myocardial high energy phosphates in pigs subjected to cardioplegic arrest Ann. Thorac. Surg., February 1, 2004; 77(2): 658 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Chen, C. X. Chen, X. T. Gan, N. Beier, W. Scholz, and M. Karmazyn Inhibition and reversal of myocardial infarction-induced hypertrophy and heart failure by NHE-1 inhibition Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H381 - H387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Nicolini, C. Beghi, C. Muscari, A. Agostinelli, A. M. Budillon, I. Spaggiari, and T. Gherli Myocardial protection in adult cardiac surgery: current options and future challenges Eur. J. Cardiothorac. Surg., December 1, 2003; 24(6): 986 - 993. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. M. Yarbrough, R. Mukherjee, G. P. Escobar, J. W. Hendrick, J. A. Sample, K. B. Dowdy, J. E. McLean, J. T. Mingoia, F. A. Crawford Jr, and F. G. Spinale Modulation of calcium transport improves myocardial contractility and enzyme profiles after prolonged ischemia-reperfusion Ann. Thorac. Surg., December 1, 2003; 76(6): 2054 - 2061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Pernow, F. Bohm, E. Beltran, and A. Gonon L-Arginine protects from ischemia-reperfusion-induced endothelial dysfunction in humans in vivo J Appl Physiol, December 1, 2003; 95(6): 2218 - 2222. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Teshima, M. Akao, S. P. Jones, and E. Marban Cariporide (HOE642), a Selective Na+-H+ Exchange Inhibitor, Inhibits the Mitochondrial Death Pathway Circulation, November 4, 2003; 108(18): 2275 - 2281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Corvera, Z.-Q. Zhao, L. S. Schmarkey, S. L. Katzmark, J. M. Budde, C. D. Morris, T. Ehring, R. A. Guyton, and J. Vinten-Johansen Optimal dose and mode of delivery of Na+/H+ exchange-1 inhibitor are critical for reducing postsurgical ischemia-reperfusion injury Ann. Thorac. Surg., November 1, 2003; 76(5): 1614 - 1622. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. M. Yarbrough, R. Mukherjee, G. P. Escobar, J. T. Mingoia, J. A. Sample, J. W. Hendrick, K. B. Dowdy, J. E. McLean, R. E. Stroud, and F. G. Spinale Direct inhibition of the sodium/hydrogen exchanger after prolonged regional ischemia improves contractility on reperfusion independent of myocardial viability J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1489 - 1497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Rabkin, S. E. Cabreriza, F. H. Cheema, A. A. Hill, L. J. Curtis, R. R. Sciacca, R. S. Mosca, and H. M. Spotnitz Cariporide is cardioprotective after iatrogenic ventricular fibrillation in the intact swine heart Ann. Thorac. Surg., October 1, 2003; 76(4): 1264 - 1269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Rabkin, S. E. Cabreriza, J. C. LaCorte, A. D. Weinberg, L. Coku, R. Walsh, R. Mosca, and H. M. Spotnitz Sodium-hydrogen exchange inhibition preserves ventricular function after ventricular fibrillation in the intact swine heart J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1499 - 1509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M. Ayoub, J. Kolarova, Z. Yi, A. Trevedi, H. Deshmukh, D. L. Lubell, M. R. Franz, F. A. Maldonado, and R. J. Gazmuri Sodium-Hydrogen Exchange Inhibition During Ventricular Fibrillation: Beneficial Effects on Ischemic Contracture, Action Potential Duration, Reperfusion Arrhythmias, Myocardial Function, and Resuscitability Circulation, April 8, 2003; 107(13): 1804 - 1809. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Rodriguez-Sinovas, D. Garcia-Dorado, F. Padilla, J. Inserte, J. A. Barrabes, M. Ruiz-Meana, L. Agullo, and J. Soler-Soler Pre-treatment with the Na+/H+ exchange inhibitor cariporide delays cell-to-cell electrical uncoupling during myocardial ischemia Cardiovasc Res, April 1, 2003; 58(1): 109 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G Allen and X.-H. Xiao Role of the cardiac Na+/H+ exchanger during ischemia and reperfusion Cardiovasc Res, March 15, 2003; 57(4): 934 - 941. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. I Bak and J. S Ingwall Contribution of Na+/H+ exchange to Na+ overload in the ischemic hypertrophied hyperthyroid rat heart Cardiovasc Res, March 15, 2003; 57(4): 1004 - 1014. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. P. Magee, G. Deshmukh, M. P. Deninno, J. C. Sutt, J. G. Chapman, and W. R. Tracey Differing cardioprotective efficacy of the Na+/Ca2+ exchanger inhibitors SEA0400 and KB-R7943 Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H903 - H910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Mentzer Jr, R. D. Lasley, A. Jessel, and M. Karmazyn Intracellular sodium hydrogen exchange inhibition and clinical myocardial protection Ann. Thorac. Surg., February 1, 2003; 75(2): S700 - 708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. K. Das Attenuation of postischemic myocardial injury by cariporide J. Thorac. Cardiovasc. Surg., January 1, 2003; 125(1): 30 - 31. [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Mentzer Jr., M. S. Jahania, and R. D. Lasley Myocardial Protection Card. Surg. Adult, January 1, 2003; 2(2003): 413 - 438. [Full Text]
|
|
|
|
|
|
M. Castella, G. D. Buckberg, Z. Tan, and L. J. Ignarro Myocyte and endothelial effects of preconditioning the jeopardized heart by inhibiting Na+/H+ exchange J. Thorac. Cardiovasc. Surg., December 1, 2002; 124(6): 1113 - 1121. [Abstract] [Full Text]
|
|
|
|
|
|
C.-K. Wong, J.K. French, M.W. Krucoff, W. Gao, P.E. Aylward, and H.D. White Slowed ST segment recovery despite early infarct artery patency in patients with Q waves at presentation with a first acute myocardial infarction. Implications of initial Q waves on myocyte reperfusion Eur. Heart J., September 2, 2002; 23(18): 1449 - 1455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-r. Wann, M. H. Weil, S. Sun, W. Tang, and T. Yu Cariporide for Pharmacologic Defibrillation After Prolonged Cardiac Arrest Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2002; 7(3): 161 - 169. [Abstract] [PDF]
|
|
|
|
|
|
Q.-D. Wang, J. Pernow, P.-O. Sjoquist, and L. Ryden Pharmacological possibilities for protection against myocardial reperfusion injury Cardiovasc Res, July 1, 2002; 55(1): 25 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Smith Jr, D. Faxon, W. Cascio, H. Schaff, T. Gardner, A. Jacobs, S. Nissen, and R. Stouffer Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group VI: Revascularization in Diabetic Patients Circulation, May 7, 2002; 105 (18): e165 - e169. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Engelhardt, L. Hein, U. Keller, K. Klambt, and M. J. Lohse Inhibition of Na+-H+ Exchange Prevents Hypertrophy, Fibrosis, and Heart Failure in {beta}1-Adrenergic Receptor Transgenic Mice Circ. Res., April 19, 2002; 90(7): 814 - 819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Loennechen, U. Wisloff, G. Falck, and O. Ellingsen Effects of Cariporide and Losartan on Hypertrophy, Calcium Transients, Contractility, and Gene Expression in Congestive Heart Failure Circulation, March 19, 2002; 105(11): 1380 - 1386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Avkiran and M. S. Marber Na+/h+ exchange inhibitors for cardioprotective therapy: progress, problems and prospects J. Am. Coll. Cardiol., March 6, 2002; 39(5): 747 - 753. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Redlin, J. Werner, H. Habazettl, W. Griethe, H. Kuppe, and A. R. Pries Cariporide (HOE 642) Attenuates Leukocyte Activation in Ischemia and Reperfusion Anesth. Analg., December 1, 2001; 93(6): 1472 - 1479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Khadilkar, P. Iannuzzi, and J. Orlowski Identification of Sites in the Second Exomembrane Loop and Ninth Transmembrane Helix of the Mammalian Na+/H+ Exchanger Important for Drug Recognition and Cation Translocation J. Biol. Chem., November 16, 2001; 276(47): 43792 - 43800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Zeymer, H. Suryapranata, J. P. Monassier, G. Opolski, J. Davies, G. Rasmanis, G. Linssen, U. Tebbe, R. Schroder, R. Tiemann, et al. The Na+/H+ exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction: Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial J. Am. Coll. Cardiol., November 15, 2001; 38(6): 1644 - 1650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. B. A. Menown and A. A. J. Adgey Cardioprotective therapy and sodium-hydrogen exchange inhibition: current concepts and future goals J. Am. Coll. Cardiol., November 15, 2001; 38(6): 1651 - 1653. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Danchin Recent advances in cardioprotection during myocardial revascularization procedures: benefit of a metabolic intervention Eur. Heart J. Suppl., November 1, 2001; 3(suppl_O): O21 - O25. [Abstract] [PDF]
|
|
|
|
|
|
M. Marzilli and M. Mariani About EMIP-FR and reperfusion damage in AMI: a comment to the comment Eur. Heart J., June 1, 2001; 22(11): 973 - 975. [PDF]
|
|
|
|
|
|
D. G Allen and X.-h. Xiao Na+ entry during ischemia, reperfusion and preconditioning Cardiovasc Res, April 1, 2001; 50(1): 164 - 166. [Full Text] [PDF]
|
|
|
|
|
|
P. Theroux, B.R. Chaitman, N. Danchin, L. Erhardt, T. Meinertz, J.S. Schroeder, G. Tognoni, H.D. White, J.T. Willerson, and A. Jessel Inhibition of the Sodium-Hydrogen Exchanger With Cariporide to Prevent Myocardial Infarction in High-Risk Ischemic Situations : Main Results of the GUARDIAN Trial Circulation, December 19, 2000; 102(25): 3032 - 3038. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Theroux Myocardial Cell Protection : A Challenging Time for Action and a Challenging Time for Clinical Research Circulation, June 27, 2000; 101(25): 2874 - 2876. [Full Text] [PDF]
|
|
|
|
|
|
S. Engelhardt, L. Hein, U. Keller, K. Klambt, and M. J. Lohse Inhibition of Na+-H+ Exchange Prevents Hypertrophy, Fibrosis, and Heart Failure in {beta}1-Adrenergic Receptor Transgenic Mice Circ. Res., April 19, 2002; 90(7): 814 - 819. [Abstract] [Full Text] [PDF]
|
|